MOLECULAR DOCKING STUDY OF QUINOLIN-4(1H)-ONE DERIVATIVES AS VEGFR-2 INHIBITORS FOR THE TREATMENT OF LUNG CANCER. FMHR. 2025;3(6):1-15. Accessed March 9, 2026. https://fmhr.net/index.php/fmhr/article/view/712